(3S,4S) -Tivantinib - CAS 905854-03-7

(3S,4S) -Tivantinib, a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET, targets GSK3α and GSK3β—two novel enzymes implicated in the pathogenesis of non-small cell lung cancer (NSCLC) [1].

Others, c-Met/HGFR

Others, Tyrosine Kinase/Adaptors

905854-03-7

C23H19N3O2

369.42

O=C1NC(=O)[C@@H]([C@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23

-20°C

Ice Packs

Small Compound